Cox Bryan F.
Chief of Research
Cox Bryan F. has filed 2 SEC Form 4 filings (4 transaction rows) across 1 company, with disclosures dating back to 2025. 2 of those filings fall inside the rolling window. Most recent filing: Mar 20, 2026.
On the most recent filing, Cox Bryan F. is listed as Chief of Research at TriSalus Life Sciences, Inc. Inside the rolling window, Cox Bryan F. reported no open-market purchases and 3 open-market sales totaling $13K in TLSI. The largest disclosed transaction in the window is a sale of 1,467 TLSI shares on Mar 12, 2026, worth $6K.
Companies traded
Other insiders at TLSI
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$13K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Cox Bryan F. made?
Cox Bryan F. has filed 2 SEC Form 4 filings (4 transaction rows) across 1 company since 2025.
Which companies does Cox Bryan F. trade?
Cox Bryan F. has filed SEC Form 4 disclosures for 1 company, including TLSI.
When was Cox Bryan F.'s most recent SEC Form 4 filing?
Cox Bryan F.'s most recent SEC Form 4 filing on Tracefour is dated Mar 20, 2026.
What is Cox Bryan F.'s job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Cox Bryan F. is listed as Chief of Research.
What is Cox Bryan F.'s total buy and sell value in the current window?
Inside the rolling retention window, Cox Bryan F. bought $0 and sold $13K based on SEC Form 4 filings.
What was Cox Bryan F.'s largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 1,467 TLSI shares on 2026-03-12, worth $6K, per SEC Form 4 filings.